Inventiva SA
PAR:IVA
Inventiva SA
Revenue
Inventiva SA
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Inventiva SA
PAR:IVA
|
Revenue
€17.5m
|
CAGR 3-Years
261%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Valneva SE
PAR:VLA
|
Revenue
€153.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
18%
|
|
Innate Pharma SA
PAR:IPH
|
Revenue
€51.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
15%
|
|
Cellectis SA
PAR:ALCLS
|
Revenue
$29.9m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Abivax SA
PAR:ABVX
|
Revenue
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
A
|
Aelis Farma SA
PAR:AELIS
|
Revenue
€3.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Inventiva SA's Revenue?
Revenue
17.5m
EUR
Based on the financial report for Dec 31, 2023, Inventiva SA's Revenue amounts to 17.5m EUR.
What is Inventiva SA's Revenue growth rate?
Revenue CAGR 5Y
40%
Over the last year, the Revenue growth was 44%. The average annual Revenue growth rates for Inventiva SA have been 261% over the past three years , 40% over the past five years .